X

Scott Willis

Aphria Q3 2019 Earnings Review – Headlines Create Opportunity

Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.

Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want

Organigram (CVE: OGI) posted another strong quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 13th, 2019)

A weekly review of the most important marijuana stock news to impact your portfolio. From legalization developments to acquisitions, we…

Canadian Cannabis Scorecard (Spring 2019)

Confused about which marijuana stocks are worth your money? The Canadian Cannabis Scorecard is your guide to separating the best…

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 6th, 2019)

German Cultivation Bid Finally Awarded Bottom Line: Each lot is only worth about C$2 mm a year in revenue. This…

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (March 30th, 2019)

SAFE Banking Act Passes First Step Bottom Line: The SAFE act would open up the banking system to cannabis companies…

Lyft Stock Guide – Transportation Disruptor or Money Pit?

With Lyft kicking off the ride-sharing IPO battle against Uber, we've delved into the ride-hailing business model and potential profitability…

Cronos Q4 2018 Earnings Review – The New Most Expensive Stock in Cannabis

In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with…

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (March 23rd, 2019)

A weekly review of only the most important cannabis news to impact your portfolio, including Curaleaf earnings, California marijuana supply…